Skip to main content

NovoCure Limited (NASDAQ: NVCR) Investor Securities Class Action Lawsuit 06/19/2023

  • If you purchased a significant amount of shares of NovoCure Limited (NASDAQ: NVCR) between January 5, 2023 and June 5, 2023, and / or if you purchased any NASDAQ: NVCR shares prior to January 2023 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: August 18, 2023. NASDAQ: NVCR investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

November 13, 2023 - An amended complaint was filed. June 19, 2023 - An investor in shares of NovoCure Limited (NASDAQ: NVCR) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by NovoCure Limited in connection with certain allegedly false and misleading statements made between January 5, 2023 and June 5, ...

You must register (for free) or login to view the entire case.